Akebia Therapeutics’ HIF-PH inhibitor passes efficacy goals in chronic kidney disease without dialysis, but falls short on safety
September 4, 2020Medical Communications, Research and Development Akebia Therapeutics, kidney disease, pharma, vadadustat
Akebia Therapeutics has pulled back the veil on data from the second of two Phase 3 clinical trials for its …
Top Ten most popular articles on Pharmafile.com this week
September 4, 2020Medical Communications
The top 10 news stories this week largely cover coronavirus, as Sanofi is halting clinical trials treating serious COVID-19 patients …
NICE knocks back Janssen’s Spravato nasal spray for the second time in treatment-resistant depression
September 3, 2020Sales and Marketing Janssen, Spravato, depression, pharma
NICE has opted to reject Janssen’s nasal spray Spravato (esketamine) for routine use on the NHS for treatment-resistant major depressive …
MHRA gives OK to Bavencio for first-line maintenance of advanced bladder cancer via the Early Access to Medicines Scheme
September 3, 2020Sales and Marketing Bavencio, MHRA, Merck, Pfizer, UK, eams, pharma
It has been revealed that Bavencio (avelumab), jointly developed by Merck KGaA and Pfizer, has been approved by the UK …
Four COVID-19 vaccine trials backed by Operation Warp Speed will likely fail, according to a new report
September 3, 2020Research and Development
Four late-stage trials of vaccine candidates partly funded by the US Operation Warp Speed are likely to fail, according to …
Ted Cruz and 19 other GOP Senators ask FDA to remove Danco’s abortion drug Mifeprex from the market
September 3, 2020Manufacturing and Production Mifeprex, abortion
Texas Senator Ted Cruz and 19 other senators have sent a letter to the FDA urging them to take the …
J&J issues warning after teen dies from Benadryl TikTok challenge
September 3, 2020Medical Communications
One teen has died after taking large amounts of the antihistamine Benadryl as part of a social media “challenge” on …
Gilead and Jounce Therapeutics forge immuno-oncology partnership worth a potential $700m+
September 2, 2020Research and Development, Sales and Marketing Gilead, jounce, oncology, pharma
Gilead and Jounce Therapeutics have come together in a new immuno-oncology partnership potentially worth over $700 million. The primary drive …
US won’t join COVAX coronavirus vaccine initiative because it is linked to the WHO
September 2, 2020Research and Development Trump, Trump Administration, US, USA
The US has said it will not participate in an international effort to develop and distribute a coronavirus vaccine.COVAX is …
Novo Nordisk launches new Rybelsus pill for type 2 diabetes in the UK
September 2, 2020Research and Development Novo Nordisk, diabetes, type 2, type 2 diabetes
Novo Nordisk’s new type 2 diabetes treatment Rybelsus is now available for doctors and physicians in the UK to prescribe …
Nestlé to acquire remaining shares in Aimmune for $2.6 billion
September 2, 2020Research and Development, Sales and Marketing Aimmune, acquisition, nestle, pharma
Food and drink giant Nestlé has confirmed it is in motion to scoop up the remaining shares in Californian biotech …
Pharmafile.com’s weekly COVID-19 news round-up
September 2, 2020Research and Development
The COVID-19 news round-up this week focuses on coronavirus treatments, with Celltrion Group announcing that the Korean Ministry of Food …
Daiichi Sankyo’s Nilemdo “significantly” reduces cholesterol levels at ESC 2020
September 1, 2020Manufacturing and Production, Research and Development Daiichi Sankyo, Nilemdo, pharma
Daiichi Sankyo has unveiled promising new benefit for Nilemdo (bempedoic acid) at the ESC Congress 2020 over the weekend for …
Oxford University’s COVID-19 vaccine begins Phase 3 trial in the US
September 1, 2020Manufacturing and Production
AstraZeneca has started a Phase 3 trial of its experimental coronavirus vaccines in the US, making it the third company …
Hong Kong rolls out free universal coronavirus testing programme
September 1, 2020Manufacturing and Production
Hong Kong has begun a free universal COVID-19 testing programme to help combat the coronavirus. This mass testing system will …
Sanofi halts Phase 3 trial of Kevzara as a COVID-19 treatment
September 1, 2020Manufacturing and Production COVID-19, Sanofi, Vaccine, pharma
Sanofi is halting clinical trials treating serious COVID-19 patients with its Kevzara drug after data on its efficacy proved inconclusive.The …
AstraZeneca’s Farxiga combo shows promise at Phase 3 in late-stage chronic kidney disease
September 1, 2020Manufacturing and Production AstraZeneca, ESC Congress 2020, pharma
AstraZeneca took the opportunity at the digital ESC Congress 2020 over the weekend to reveal promising new Phase 3 data …
University of Illinois at Chicago’s new breast cancer drug is safe and can halt disease progression, according to a Phase 1 trial
August 28, 2020Medical Communications Cancer, Cancers, breast cancer
A new breast cancer drug, called TTC-352, can halt the spread of the disease and is safe according to a …
US signs deal to buy 150 million rapid COVID-19 tests from Abbott
August 28, 2020Medical Communications
The US government has signed a deal to buy Abbott’s rapid coronavirus test after the FDA gave it Emergency Use …
First clinical trial for MDMA and LSD combination set to go ahead
August 28, 2020Medical Communications LSD, MDMA, PTSD
Researchers are set to investigate a combined dose of LSD and MDMA to treat patients undergoing psychotherapy. The Phase 1 …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
